ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesJ18.1

J18.1

Lobar pneumonia, unspecified organism

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 J18.1 is a billable code used to indicate a diagnosis of lobar pneumonia, unspecified organism.

Key Diagnostic Point:

Lobar pneumonia, unspecified organism, is a type of pneumonia characterized by the inflammation of a large and continuous area of the lobe of a lung. This condition can arise from various infectious agents, including bacteria, viruses, and fungi, though the specific organism is not identified in this code. Clinically, patients may present with symptoms such as cough, fever, chills, pleuritic chest pain, and difficulty breathing. The anatomy involved primarily includes the lung lobes, which are sections of the lungs that can become consolidated with fluid and inflammatory cells during infection. Disease progression can vary; in some cases, it may resolve with appropriate treatment, while in others, it can lead to complications such as abscess formation or respiratory failure. Diagnostic considerations include chest X-rays or CT scans to visualize the extent of lung involvement, along with sputum cultures or blood tests to identify the causative organism when possible. However, in cases where the organism remains unspecified, treatment is often empirical, focusing on broad-spectrum antibiotics.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Moderate, as the organism is unspecified, requiring clinical judgment for treatment.
  • Treatment complexity: Moderate, due to the need for empirical antibiotic therapy and monitoring for complications.
  • Documentation requirements: Moderate, necessitating detailed clinical notes to support diagnosis and treatment.
  • Coding specificity: Medium, as it lacks specificity regarding the causative agent.

Audit Risk Factors

  • Common coding errors: Misidentifying the organism or using a more specific code when J18.1 is appropriate.
  • Documentation gaps: Incomplete clinical notes that do not adequately describe the patient's condition or treatment.
  • Billing challenges: Potential denials if documentation does not clearly support the diagnosis of lobar pneumonia.

Specialty Focus

Medical Specialties

Primary medical specialty: Pulmonology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Secondary specialty: Internal Medicine

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Lobar pneumonia, unspecified organism, significantly impacts population health, contributing to morbidity and healthcare utilization. It is a common cause of hospitalization, particularly among vulnerable populations such as the elderly and those with underlying health conditions. Quality measures often focus on timely diagnosis and treatment, as well as the prevention of complications. Understanding the epidemiology of lobar pneumonia can help healthcare providers implement effective prevention strategies, such as vaccination and public health initiatives.

ICD-9 vs ICD-10

Lobar pneumonia, unspecified organism, significantly impacts population health, contributing to morbidity and healthcare utilization. It is a common cause of hospitalization, particularly among vulnerable populations such as the elderly and those with underlying health conditions. Quality measures often focus on timely diagnosis and treatment, as well as the prevention of complications. Understanding the epidemiology of lobar pneumonia can help healthcare providers implement effective prevention strategies, such as vaccination and public health initiatives.

Reimbursement & Billing Impact

Reimbursement considerations include the need for thorough documentation to avoid denials, particularly if the diagnosis is not clearly supported. Common denials may arise from insufficient documentation or failure to demonstrate medical necessity for the services rendered. Best practices include using appropriate modifiers and ensuring that all services are linked to the diagnosis code.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by J18.1?

J18.1 covers lobar pneumonia where the specific causative organism is not identified. This can include cases where the pneumonia is suspected to be bacterial, viral, or fungal but not confirmed through laboratory testing.

When should J18.1 be used instead of related codes?

J18.1 should be used when a patient presents with lobar pneumonia but the organism has not been identified. If the organism is known, a more specific code should be selected, such as J18.0 for pneumonia due to Streptococcus pneumoniae.

What documentation supports J18.1?

Documentation should include clinical findings such as symptoms, physical examination results, imaging studies, and any laboratory tests performed. It should also note the absence of organism identification and the rationale for treatment decisions.